Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis
Overview
Authors
Affiliations
Objective: Forced vital capacity (FVC) and DLCO are used for screening of systemic sclerosis-associated interstitial lung disease (SSc-ILD). The study purpose was to determine the sensitivity, specificity, and negative predictive value (NPV) (proportion of true negative screening tests) of FVC and DLCO thresholds for SSc-ILD on chest high-resolution computed tomography (HRCT) scans.
Methods: Patients fulfilling American College of Rheumatology 2013 SSc criteria with a chest HRCT scan and pulmonary function tests (PFT) were studied. A thoracic radiologist quantified radiographic ILD. Optimal FVC and DLCO % predicted thresholds for ILD were identified using receiver-operating characteristic curves. The FVC and DLCO combinations with greatest sensitivity and specificity were also determined. Subanalysis was performed in patients with positive Scl-70 autoantibodies.
Results: The study included 265 patients. Of 188 (71%) with radiographic ILD, 59 (31%) had "normal" FVC (≥ 80% predicted), and 65 out of 151 (43%) had "normal" DLCO (≥ 60% predicted). FVC < 80% (sensitivity 0.69, specificity 0.73), and DLCO < 62% (sensitivity 0.60, specificity 0.70) were optimal thresholds for radiographic SSc-ILD. All FVC and DLCO threshold combinations evaluated had NPV < 0.70. The NPV for radiographic ILD for FVC < 80% was lower in patients with positive Scl-70 autoantibody (NPV = 0.05) compared to negative Scl-70 autoantibody (NPV = 0.57).
Conclusion: Radiographic ILD is prevalent in SSc despite "normal" PFT. No % predicted FVC or DLCO threshold combinations yielded high NPV for SSc-ILD screening. "Normal" FVC and DLCO in patients with SSc, especially those with positive Scl-70 autoantibodies, should not obviate consideration of HRCT for ILD evaluation.
Reichenberger F, Popp F, Hoffmann M, Fischinger C, von Wulffen W, Kneidinger N BMC Pulm Med. 2024; 24(1):581.
PMID: 39578822 PMC: 11585148. DOI: 10.1186/s12890-024-03405-y.
Amorim F, Dos Santos E, Yuji Verrastro C, Kayser C PLoS One. 2024; 19(9):e0310892.
PMID: 39331602 PMC: 11432915. DOI: 10.1371/journal.pone.0310892.
Good S, Sparks J, Volkmann E Rev Colomb Reumatol. 2024; 31(Suppl 1):S3-S14.
PMID: 39238598 PMC: 11376317. DOI: 10.1016/j.rcreu.2023.06.002.
De Angelis R, Cipolletta E, Francioso F, Carotti M, Farah S, Giovagnoni A J Pers Med. 2024; 14(6).
PMID: 38929856 PMC: 11205232. DOI: 10.3390/jpm14060635.
Gutierrez M, Bertolazzi C, Zozoaga-Velazquez E, Clavijo-Cornejo D Tomography. 2024; 10(4):521-532.
PMID: 38668398 PMC: 11054173. DOI: 10.3390/tomography10040041.